Shareholding for the Period Ended December 31, 2017
Jubilant Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click here20-01-2018
20-01-2018
Broker's Call: Jubilant Life (Buy)
JMFLJubilant Life (Buy)CMP: 899.75Target: 930In 3QFY18, Jubilant Lifescience's Revenue/EBITDA/PAT of 2,067.8/416.8/212.5 crore were 5 per cent/11 per cent/24 per cent above our estimates mainly...18-01-2018
Updates
In continuation of our letter dated January 17, 2018, we enclose copies of the Unaudited Consolidated Financial Results for the quarter ended December 31, 2017 published on January 18, 2018 in MINT (English) and HINDUSTAN (Hindi).18-01-2018
Jubilant Life Sciences Q3 net surges 80% to Rs 2.12 bn on robust sales
The company continues to reduce debt levels through internal cash generation for a strong balance sheet17-01-2018
Updates
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has issued Commercial Papers ('CPs') of Rs. 90 crore on January 17, 2018. Details of the same are mentioned in the attached letter.17-01-2018
Change in Directorate
Changes in the Board of Directors Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform about the following changes in the Board of Directors: 1.Resignation of Mr. Pramod Yadav: Consequent to his appointment as CEO Designate of Jubilant Pharma Limited, a wholly owned subsidiary of the Company, Mr Pramod Yadav...17-01-2018
Financial Results For The Quarter Ended December 31, 2017
Dear Sirs, In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended December 31, 2017 were approved by the Board of Directors of the Company at its meeting held today at 1.15 p.m. and concluded at 2.20 p.m....17-01-2018
Clarifies on news item
With reference to news appeared in www.economictimes.indiatimes.com dated January 15, 2018 quoting "Jubilant Life gets green nod for Rs 250-cr pesticide project", Jubilant Life Sciences Ltd has submitted to BSE a copy of Clarification is enclosed.15-01-2018
Clarification sought from Jubilant Life Sciences Ltd
The Exchange has sought clarification from Jubilant Life Sciences Ltd on January 15, 2018, with reference to news appeared in www.economictimes.indiatimes.com dated January 15, 2018 quoting "Jubilant Life gets green nod for Rs 250-cr pesticide project".The reply is awaited.15-01-2018
Jubilant Life gets green nod for Rs250 crore pesticide project
Jubilant Life Sciences has received a green nod for setting up a greenfield pesticide manufacturing unit at Bharuch, Gujarat at a cost of around Rs250 crore, as per the official document14-01-2018